» Articles » PMID: 31624858

Activation of ATR-related Protein Kinase Upon DNA Damage Recognition

Overview
Journal Curr Genet
Specialty Genetics
Date 2019 Oct 19
PMID 31624858
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Chromosomes are constantly damaged by exogenous and endogenous factors. To cope with DNA damage, eukaryotic cells are equipped with three phosphatidylinositol 3-kinase-related kinases (PIKKs), such as ATM, ATR, and DNA-PK. PIKKs are structurally related to phosphatidylinositol 3-kinase (lipid kinase), however possess protein kinase activities. The Mre11-Rad50-Nbs1 and the Ku complex interact with and activate ATM and DNA-PKcs at double-stranded DNA breaks (DSBs), respectively. In contrast, ATR responds to various types of DNA lesions by interacting with replication protein A (RPA)-covered single-stranded DNA (ssDNA). Several lines of evidence have established a model in which ATR is activated by interacting with ATR activating proteins including TopBP1 and ETAA1 at DNA lesions in humans, yet the interaction of ATR with RPA-covered ssDNA does not result in ATR activation. In budding yeast, the Mec1-Ddc2 complex (Mec1-Ddc2) corresponds to ATR-ATRIP. Similar to ATR, Mec1 activation is accomplished by interactions with Mec1 activating proteins, which are Ddc1, Dpb11 (TopBP1 homolog) and Dna2. However, recent studies provide results supporting the idea that Mec1 is also activated by interacting with RPA-covered ssDNA tracts. These observations suggest that all the ATM, ATR, DNA-PK family proteins can be activated immediately upon DNA damage recognition.

Citing Articles

Differential Effects of Biomimetic Thymine Dimers and Corresponding Photo-Adducts in Primary Human Keratinocytes and Fibroblasts.

Monetta R, Campagna D, Bartolocci V, Capone A, Teson M, Filippi S Biomolecules. 2025; 14(12.

PMID: 39766191 PMC: 11726716. DOI: 10.3390/biom14121484.


Myriad factors and pathways influencing tumor radiotherapy resistance.

Mi L, Zhang H Open Life Sci. 2024; 19(1):20220992.

PMID: 39655194 PMC: 11627069. DOI: 10.1515/biol-2022-0992.


DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study.

Krasniqi E, Ercolani C, Di Benedetto A, Di Lisa F, Filomeno L, Arcuri T Cancers (Basel). 2024; 16(15).

PMID: 39123356 PMC: 11311544. DOI: 10.3390/cancers16152628.


Protein Phosphatase 2ACα Regulates ATR-Mediated Endogenous DNA Damage Response Against Microcephaly.

Lin L, Ding J, Liu S, Liu C, Li Q, Gao X Mol Neurobiol. 2024; 62(1):1266-1281.

PMID: 38976130 DOI: 10.1007/s12035-024-04301-6.


Deciphering the role of post-translational modifications in fanconi anemia proteins and their influence on tumorigenesis.

Ma R, Xu X Cancer Gene Ther. 2024; 31(8):1113-1123.

PMID: 38879655 DOI: 10.1038/s41417-024-00797-1.


References
1.
Chen S, Zhou H . Reconstitution of Rad53 activation by Mec1 through adaptor protein Mrc1. J Biol Chem. 2009; 284(28):18593-604. PMC: 2707194. DOI: 10.1074/jbc.M109.018242. View

2.
Wang X, Ran T, Zhang X, Xin J, Zhang Z, Wu T . 3.9 Å structure of the yeast Mec1-Ddc2 complex, a homolog of human ATR-ATRIP. Science. 2017; 358(6367):1206-1209. DOI: 10.1126/science.aan8414. View

3.
Singh B, Wu P . Linking the organization of DNA replication with genome maintenance. Curr Genet. 2019; 65(3):677-683. DOI: 10.1007/s00294-018-0923-8. View

4.
Elledge S . Cell cycle checkpoints: preventing an identity crisis. Science. 1996; 274(5293):1664-72. DOI: 10.1126/science.274.5293.1664. View

5.
Coutelier H, Xu Z . Adaptation in replicative senescence: a risky business. Curr Genet. 2019; 65(3):711-716. DOI: 10.1007/s00294-019-00933-7. View